These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37341139)

  • 21. Analysis of the risk factors of linezolid-related haematological toxicity in Chinese patients.
    Dai Y; Jiang S; Chen X; Han L; Zhang C; Yu X; Zhang X
    J Clin Pharm Ther; 2021 Jun; 46(3):807-813. PubMed ID: 33555057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination.
    Kaya Kılıç E; Bulut C; Sönmezer MÇ; Ozel Ö; Ataman Hatipoğlu Ç; Tuncer Ertem G; Tülek N; Kınıklı S
    J Infect Dev Ctries; 2019 Oct; 13(10):886-891. PubMed ID: 32084018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature.
    Cossu AP; Musu M; Mura P; De Giudici LM; Finco G
    Eur J Clin Pharmacol; 2014 Jan; 70(1):23-8. PubMed ID: 24022332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
    Nukui Y; Hatakeyama S; Okamoto K; Yamamoto T; Hisaka A; Suzuki H; Yata N; Yotsuyanagi H; Moriya K
    J Antimicrob Chemother; 2013 Sep; 68(9):2128-33. PubMed ID: 23625638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linezolid-Induced Thrombocytopenia in Patients with Renal Impairment: A Case Series, Review and Dose Advice.
    Laarhuis SRE; Kerskes CHM; Nijziel MR; van Wensen RJA; Touw DJ
    Drugs R D; 2024 Mar; 24(1):109-115. PubMed ID: 38480595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for linezolid-induced thrombocytopenia in adult inpatients.
    Han X; Wang J; Zan X; Peng L; Nie X
    Int J Clin Pharm; 2022 Apr; 44(2):330-338. PubMed ID: 34731363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose optimisation of linezolid in critically ill patients based on a population pharmacokinetic model: A two-centre prospective interventional study.
    Shi L; Zhang Y; Duan L; Huang L; Li J; Lu J; Zhuang Z; Yuan Y; Feng Z; Sun J; Liu X; Zhou Q; Xue H; Xu J; Tang L
    Int J Antimicrob Agents; 2023 Aug; 62(2):106881. PubMed ID: 37301313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of Major Linezolid Metabolites in Patients with Renal Impairment.
    Souza E; Crass RL; Felton J; Hanaya K; Pai MP
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective test for a possible relationship between linezolid-induced thrombocytopenia and hyponatraemia.
    Tanaka R; Suzuki Y; Morinaga Y; Iwao M; Takumi Y; Hashinaga K; Tatsuta R; Hiramatsu K; Kadota JI; Itoh H
    J Clin Pharm Ther; 2021 Apr; 46(2):343-351. PubMed ID: 33016566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.
    Crass RL; Cojutti PG; Pai MP; Pea F
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of vancomycin or linezolid therapy on development of renal dysfunction and thrombocytopenia in Japanese patients.
    Fujii S; Takahashi S; Makino S; Kunimoto Y; Nakata H; Noda N; Sakurai K; Miyamoto A
    Chemotherapy; 2013; 59(5):319-24. PubMed ID: 24480883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
    Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
    J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.
    Tessier JM; Puzio T; Young A; Wolfe L; Han J; Duane TM
    Surg Infect (Larchmt); 2015 Aug; 16(4):361-7. PubMed ID: 26207396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.
    Tsuji Y; Holford NHG; Kasai H; Ogami C; Heo YA; Higashi Y; Mizoguchi A; To H; Yamamoto Y
    Br J Clin Pharmacol; 2017 Aug; 83(8):1758-1772. PubMed ID: 28186644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Regression Model to Predict Linezolid Induced Thrombocytopenia in Neonatal Sepsis Patients: A Ten-Year Retrospective Cohort Study.
    Duan L; Zhou Q; Feng Z; Zhu C; Cai Y; Wang S; Zhu M; Li J; Yuan Y; Liu X; Sun J; Yang Z; Tang L
    Front Pharmacol; 2022; 13():710099. PubMed ID: 35185555
    [No Abstract]   [Full Text] [Related]  

  • 36. Bicytopenia, especially thrombocytopenia in hemodialysis and non-hemodialysis patients treated with linezolid therapy.
    Kato H; Hamada Y; Hagihara M; Hirai J; Yamagishi Y; Matsuura K; Mikamo H
    J Infect Chemother; 2015 Oct; 21(10):707-12. PubMed ID: 26231318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients.
    Wicha SG; Mair A; Chiriac U; Frey OR; Fuchs T; Gaasch M; Hagel S; Richter DC; Roberts JA; Röhr AC; Weigand MA; Brinkmann A
    Int J Antimicrob Agents; 2022 May; 59(5):106572. PubMed ID: 35307562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk factors for severe linezolid-associated thrombocytopenia in pediatric patients: An analysis of a public database.
    Yang S; Guo W; Chen M; Hu J; Feng N; Ju M; Qian Y
    Medicine (Baltimore); 2023 Jun; 102(24):e34059. PubMed ID: 37327288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid induced thrombocytopenia in critically ill patients: Risk factors and development of a machine learning-based prediction model.
    Maray I; Rodríguez-Ferreras A; Álvarez-Asteinza C; Alaguero-Calero M; Valledor P; Fernández J
    J Infect Chemother; 2022 Sep; 28(9):1249-1254. PubMed ID: 35581121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A risk factor-based predictive model for linezolid-induced anaemia: A 7-year retrospective study.
    Qin Y; Liu Y; Chen Z; Cao M; Shen Y; Ye Y
    J Clin Pharm Ther; 2021 Dec; 46(6):1591-1599. PubMed ID: 34287998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.